ClinicalTrials.Veeva

Menu

the Value of Flexible Bronchoscopy in the Neonatal Intensive Care Unit at Sohag University Hospitals

S

Sohag University

Status

Active, not recruiting

Conditions

Study Including Neonates Who Underwent Flexible Fiberoptic Bronchoscopy in Last 10 Years at Sohag University Hospitals

Treatments

Diagnostic Test: retrospective study including neonates who underwent flexible fiberoptic bronchoscopy over a period of 10 years from January 2015 to January 2025.

Study type

Interventional

Funder types

Other

Identifiers

NCT07211971
Soh-Med-25-9-10MS

Details and patient eligibility

About

The aim of this study to describe the utility of flexible fiberoptic bronchoscopy for the diagnosis and management of different respiratory diseases in the neonatal ICU.

Full description

Study including neonates who underwent flexible fiberoptic bronchoscopy over a period of 10 years from January 2015 to January 2025. The study population comprised neonates admitted to the NICU in Sohag University Hospitals between January 2015 and january 2025.

  • The inclusion criteria were neonates aged from 1 day to 28 days with recurrent dyspnea, stridor, recurrent chocking or suspicious respiratory tract anomaly; with recurrent pulmonary infection or atelectasis in the same lung lobe; with suspicious tracheal stenosis in radiological image [X-ray or computed tomography (CT) scan]; inability to be extubated without clear reason; or confirmed congenital esophageal atresia to clarify the presence and position of esophagobronchial fistula before surgery.
  • Exclusion criteria : neonates with neurological , cardiac problem ,age above 28 days Clinical data such as age, sex; weight at bronchoscopy; mechanical ventilation during hospitalization.
  • Clinical indications and results of bronchoscopy were also retrospectively collected.
  • Medical and surgical intervention needed for management after diagnosis by FB.

Enrollment

100 estimated patients

Sex

All

Ages

1 to 28 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • neonates aged from 1 day to 28 days with recurrent dyspnea, stridor, recurrent chocking or suspicious respiratory tract anomaly; with recurrent pulmonary infection or atelectasis in the same lung lobe; with suspicious tracheal stenosis in radiological image [X-ray or computed tomography (CT) scan]; inability to be extubated without clear reason; or confirmed congenital esophageal atresia to clarify the presence and position of esophagobronchial fistula before surgery.

Exclusion criteria

neonates with neurological , cardiac problem ,age above 28 days

-

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

neonates who underwent flexible fiberoptic bronchoscopy
Other group
Treatment:
Diagnostic Test: retrospective study including neonates who underwent flexible fiberoptic bronchoscopy over a period of 10 years from January 2015 to January 2025.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems